89 related articles for article (PubMed ID: 21552846)
21. Estramustine binding protein in primary tumours and metastases of malignant melanoma.
von Schoultz E; Carlström K; Henriksson R; Lagerlöf B; Hansson J
Melanoma Res; 1994 Dec; 4(6):401-5. PubMed ID: 7703721
[TBL] [Abstract][Full Text] [Related]
22. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
Björk PA; Flüchter SH; Nelde HJ
Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
[TBL] [Abstract][Full Text] [Related]
23. Production of monoclonal antibody against the C1 component of rat estramustine-binding protein: immunohistochemical study of rat prostate.
Tamura Y; Yuasa H; Suzuki T; Yamanaka H; Suzuki K
Histochem Cell Biol; 1995 Dec; 104(6):429-33. PubMed ID: 8777728
[TBL] [Abstract][Full Text] [Related]
24. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
[TBL] [Abstract][Full Text] [Related]
25. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
von Schoultz E; Lundblad D; Bergh J; Grankvist K; Henriksson R
Br J Cancer; 1988 Sep; 58(3):326-9. PubMed ID: 3052561
[TBL] [Abstract][Full Text] [Related]
26. Estramustine-binding protein in meningioma.
Karlsson AE; Bergenheim AT; Björk P; Henriksson R
Acta Neuropathol; 1999 Aug; 98(2):135-40. PubMed ID: 10442552
[TBL] [Abstract][Full Text] [Related]
27. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
[TBL] [Abstract][Full Text] [Related]
28. Expression of estramustine-binding protein (EMBP) and the proliferation-associated antigen Ki-67 in prostatic carcinomas.
Nilsson S; Nordgren H; Karlberg L; Harvig B; Busch C; Hall T; Björk P
Scand J Urol Nephrol Suppl; 1988; 110():31-7. PubMed ID: 3187428
[TBL] [Abstract][Full Text] [Related]
29. High-grade astrocytoma treated concomitantly with estramustine and radiotherapy.
Henriksson R; Malmström A; Bergström P; Bergh G; Trojanowski T; Andreasson L; Blomquist E; Jonsborg S; Edekling T; Salander P; Brännström T; Bergenheim AT
J Neurooncol; 2006 Jul; 78(3):321-6. PubMed ID: 16598426
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
31. Purification of 45 KDa estramustine binding protein (EMBP) and preparation of its antibody.
Yuasa H; Yamanaka H; Imai K; Mashimo T; Kohno H
Hinyokika Kiyo; 1990 Feb; 36(2):121-5. PubMed ID: 2343804
[TBL] [Abstract][Full Text] [Related]
32. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
33. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
34. Distribution of radioiodinated estramustine binding protein antibody in mice with DU-145 prostate cancer xenograft.
Ståhlberg K; Kairemo K; Karonen SL; Taari K; Rannikko S
Anticancer Res; 2007; 27(4B):2275-8. PubMed ID: 17695514
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Drucker KL; Gianinni C; Decker PA; Diamandis EP; Scarisbrick IA
BMC Cancer; 2015 Aug; 15():565. PubMed ID: 26231762
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of the RNA-binding motif protein 3 in human astrocytoma.
Zhang HT; Zhang ZW; Xue JH; Kong HB; Liu AJ; Li SC; Liu YX; Xu DG
Chin Med J (Engl); 2013; 126(10):1948-52. PubMed ID: 23673116
[TBL] [Abstract][Full Text] [Related]
37. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
38. Nerve growth factor expression in astrocytoma and cerebrospinal fluid: a new biomarker for prognosis of astrocytoma.
Li QY; Yang Y; Zhang Y; Zhang ZJ; Gong AH; Yuan ZC; Lu PS; Zhan LP; Wang P; Feng Y; Xu WL
Chin Med J (Engl); 2011 Jul; 124(14):2222-7. PubMed ID: 21933631
[TBL] [Abstract][Full Text] [Related]
39. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
[TBL] [Abstract][Full Text] [Related]
40. Estramustine-binding protein (EMBP).
Högberg B
Acta Urol Belg; 1980 Jan; 48(1):123-32. PubMed ID: 7435348
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
